Lucas D. Dias

Prof. Dr. Lucas D. Dias


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2024 in Life
Verified
Journal Article
Open access
PDF file
CACarly Almeida
Carly Almeida
Rodolfo P VieiraRodolfo P Vieira
Rodolfo P Vieira
OJOsvaldo Soares de Araújo Júnior
Osvaldo Soares de Araújo Júnior
PLPedro Sardinha Leonardo Lopes-Martins
Pedro Sardinha Leonardo Lopes-Martins
LSLarissa Santos
Larissa Santos
RLRodrigo Alvaro Brandão Lopes-Martins
Rodrigo Alvaro Brandão Lopes-Martins
Generalized Anxiety Disorder (GAD) is a common psychiatric condition characterized by persistent and excessive worry, often accompanied by dysautonomic symptoms that significantly impact patients’ well-being. Cannabidiol (CBD), a non-psychoactive compound derived from cannabis, has shown potential as an anxiolytic through its partial agonism of the 5HT-1A receptor and its negative allosteric modulation of CB1 receptors, which may help mitigate the anxiogenic effects of tetrahydrocannabinol (THC). This study evaluates the impact of CBD on individuals diagnosed with various anxiety disorders, comparing its effects to placebo and conventional pharmaceutical treatments through a systematic review of randomized controlled trials (RCTs). A systematic search of RCTs published between 2013 and 2023 was conducted across three databases using the terms “cannabidiol” and “anxiety”. Out of the 284 articles identified, 11 met the eligibility criteria. The studies reviewed varied widely in terms of the types of anxiety disorders and CBD dosages examined, leading to results that were often contradictory. Despite these conflicting outcomes, the data suggest that CBD may reduce anxiety with minimal adverse effects when compared to a placebo. However, further RCTs with improved methodologies, encompassing a broad range of doses and continuous CBD administration across specific anxiety disorders, are needed. Unlike previous studies and meta-analyses, this review encompasses a broader spectrum of anxiety disorders and a variety of study designs and dosages, providing a more nuanced understanding of CBD’s potential efficacy across different conditions.

8 June 2025 in Catalysts
Verified
Journal Article
Open access
PDF file
SZShahab Zomorodbakhsh
Shahab Zomorodbakhsh
Lucas D. DiasLucas D. Dias
Lucas D. Dias
Mário CalveteMário Calvete
Mário Calvete
Andreia PeixotoAndreia Peixoto
Andreia Peixoto
Rui CarrilhoRui Carrilho
Rui Carrilho
Mariette PereiraMariette Pereira
Mariette Pereira
Biochar-based materials have gathered increasing attention as sustainable catalysts for carbon dioxide (CO2) valorization, offering a green alternative to traditional metal-based systems. Produced from renewable biomass through pyrolysis, biochar possesses key features—such as high surface area, rich porosity and tunable surface chemistry—that make it particularly suited for heterogeneous catalysis. This review highlights recent advances in the use of biochar-derived catalysts for key CO2 conversion reactions, focusing on cycloaddition to epoxides, dry reforming of methane and catalytic biomass upgrading. Emphasis is given to the role of biochar’s origin and preparation methods, which critically influence its structure, surface functionality and catalytic performance. Feedstocks rich in mineral content or oxygenated groups, for instance, can enhance CO2 activation and product selectivity. Furthermore, tailored modifications—such as doping with heteroatoms or supporting metal nanoparticles—further boost catalytic activity and stability by tuning acid–base behavior, while maintaining low toxicity and cost-effectiveness. Compared to conventional catalysts, biochar-based systems offer advantages in low cost, recyclability and resistance to deactivation. Challenges remain in standardizing production methods, controlling structural variability, minimizing metal leaching and scaling up. This review presents biochar as a versatile, renewable platform for CO2 utilization, highlighting the importance of rational design, feedstock selection and functionalization strategies for developing efficient, sustainable catalytic systems, in line with green chemistry and circular economy principles.

20 November 2023 in Molecules
Verified
Journal Article
Open access
PDF file
GPGiusi Piccirillo
Giusi Piccirillo
RSRodrigo B. De Sousa
Rodrigo B. De Sousa
Lucas D. DiasLucas D. Dias
Lucas D. Dias
Mário CalveteMário Calvete
Mário Calvete
Exposure to pesticides is inevitable in modern times, and their environmental presence is strongly associated to the development of various malignancies. This challenge has prompted an increased interest in finding more sustainable ways of degrading pesticides. Advanced oxidation processes in particular appear as highly advantageous, due to their ability of selectively removing chemical entities form wastewaters. This review provides a concise introduction to the mechanisms of photochemical advanced oxidation processes with an objective perspective, followed by a succinct literature review on the photodegradation of pesticides utilizing metal oxide-based semiconductors as photosensitizing catalysts. The selection of reports discussed here is based on relevance and impact, which are recognized globally, ensuring rigorous scrutiny. Finally, this literature review explores the use of tetrapyrrolic macrocyclic photosensitizers in pesticide photodegradation, analyzing their benefits and limitations and providing insights into future directions.

20 June 2026 in Lasers in Medical Science
Verified
Journal Article
Open access
PDF file
JSJoão Salviano Simões Chagas da Silva
João Salviano Simões Chagas da Silva
LMLorena Cristina da Mata
Lorena Cristina da Mata
VMValdirene Neves Monteiro
Valdirene Neves Monteiro
EREvandro Leão Ribeiro
Evandro Leão Ribeiro
Lucas D. DiasLucas D. Dias
Lucas D. Dias
PNPlínio Lázaro Faleiro Naves
Plínio Lázaro Faleiro Naves
This study aimed to systematically evaluate the antibiofilm efficacy of curcumin-mediated antimicrobial photodynamic therapy (aPDT) activated by 450 nm LED light against biofilm formation and mature biofilms of clinically relevant Candida species, with particular emphasis on preventive potential and species-dependent susceptibility; Biofilm formation and maturation were investigated in five standard Candida strains. Biofilm formation (preventive approach) and established biofilms were treated with curcumin followed by irradiation with 450 nm LED light. Biofilm biomass was quantitatively assessed using the crystal violet assay. Comparative analyses were performed to determine species-dependent responses to aPDT. Data normality was assessed using the Shapiro-Wilk test, and intergroup comparisons were performed using the Kruskal-Wallis test followed by Dunn’s post hoc test when appropriate. All Candida strains demonstrated a pronounced ability to form biofilms, being classified as strong biofilm producers, except Candida dubliniensis , which exhibited moderate biofilm formation. Curcumin-mediated aPDT significantly inhibited biofilm development across all tested species ( p < 0.05), achieving reductions of 86.82% for C. metapsilosis , 85.05% for C. orthopsilosis , 83.33% for C. parapsilosis , 75.34% for C. dubliniensis , and 68.19% for C. albicans . This preventive antibiofilm effect is likely associated with reactive oxygen species generation, resulting in oxidative damage to essential cellular structures and impairment of early extracellular matrix establishment. In contrast, aPDT activity against mature biofilms was significantly attenuated and highly species-dependent, with reductions ranging from 49.63% ( C. parapsilosis ) to 0.64% ( C. dubliniensis ); however, these reductions were not statistically significant ( p > 0.05). Curcumin-mediated aPDT exerted a significant preventive antibiofilm effect against Candida biofilm formation but showed limited and non-significant activity against mature biofilms. These findings position curcumin-mediated aPDT as a promising strategy for preventing Candida biofilm establishment, while indicating that improved photosensitizer delivery and optimized irradiation protocols are required to enhance activity against established biofilms.

22 July 2026 in Lasers in Medical Science
Verified
Journal Article
Open access
PDF file
LCLarissa N. Castro
Larissa N. Castro
RCRafael Costa
Rafael Costa
ITIara R. Tosta
Iara R. Tosta
OSOsmar Vieira da Silva
Osmar Vieira da Silva
Lucas D. DiasLucas D. Dias
Lucas D. Dias
Neonatal jaundice, characterized by unconjugated hyperbilirubinemia, remains one of the most prevalent conditions affecting both term and preterm neonates. Elevated bilirubin levels may progress to acute bilirubin encephalopathy or kernicterus, resulting in irreversible neurological damage and increased mortality. Phototherapy is the standard treatment for neonatal hyperbilirubinemia, promoting bilirubin elimination through photoisomerization and photodegradation pathways that generate more water-soluble products, bypassing hepatic metabolism. Over the past decades, significant advances have been made in light-based technologies aimed at improving the efficiency of bilirubin photoconversion. In particular, wavelength optimization, high-intensity light-emitting diodes (LEDs) systems, and emerging photonic and nanomaterial-based approaches have been explored to enhance therapeutic outcomes. In this review, a structured literature search was conducted using the Web of Science database, covering the past 20 years, to analyze recent developments in bilirubin photoisomerization and photodegradation (in vitro and in vivo studies). The results demonstrate that photodegradation efficiency is strongly dependent on wavelength, with optimal performance observed in the blue-green region (490–500 nm), where reduced bilirubin half-life and increased lumirubin formation are reported. Furthermore, high-intensity LED systems generally provide higher irradiance and more favorable degradation kinetics than conventional light sources, although direct comparison among studies remains limited by differences in irradiation geometry, exposure time, bilirubin concentration, and experimental models. Emerging strategies, including optoacoustic monitoring, fluorescence-based theragnostic systems, and nanomaterial-assisted photocatalysis (e.g., ZnO nanoparticles, Au nanocomposites, and functionalized Fe₃O₄ systems), have demonstrated enhanced bilirubin degradation and offer new perspectives for both therapeutic optimization and real-time monitoring. However, most of these approaches remain at the proof-of-concept or preclinical stage, and their clinical translation requires validation of biocompatibility, selectivity, reproducibility, scalability, and neonatal safety. Optical and point-of-care sensing technologies may enable individualized adjustment of phototherapy, but their performance must be validated under clinically relevant conditions and across different gestational ages, skin characteristics, and bilirubin concentrations. Additionally, bilirubin degradation is not solely a detoxification process, as photooxidation products may exhibit biological activity with potential clinical implications. Future studies should therefore focus on optimizing irradiation parameters (wavelength, irradiance, and exposure time), elucidating photochemical pathways, and characterizing degradation products, while correlating these findings with clinical outcomes. Standardized experimental and clinical protocols will also be essential to compare technologies and determine whether improved photochemical performance translates into faster bilirubin reduction, shorter treatment duration, and fewer adverse effects. Such integration may support the development of more efficient, safer, and personalized phototherapy strategies in neonatal care.

14 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Mário CalveteMário Calvete
Mário Calvete
SZShahab Zomorodbakhsh
Shahab Zomorodbakhsh
Lucas D. DiasLucas D. Dias
Lucas D. Dias
JPJoão S. Pereira
João S. Pereira
JRJosé M. B. Ribeiro
José M. B. Ribeiro
Mariette PereiraMariette Pereira
Mariette Pereira
The increasing concentration of atmospheric CO2 has intensified the search for sustainable technologies capable of converting this greenhouse gas into valuable fuels and chemicals. Among the available approaches, thermocatalytic, photocatalytic, and electrochemical CO2 reduction have emerged as key strategies for carbon valorisation. In this regard, biochar-derived materials have recently attracted growing attention due to their renewable origin, tunable porosity, rich surface chemistry, and ability to support active catalytic sites. These properties enhance CO2 adsorption, activation, and charge-transfer processes, making biochar a promising platform across multiple CO2 reduction pathways. This review provides a critical overview of recent advances in thermocatalytic, photocatalytic, and electrochemical CO2 reduction using biochar-based materials, highlighting the relationship between material properties and catalytic performance. Particular attention is given to integrated capture-conversion systems, where biochar enables the coupling of CO2 adsorption and catalytic transformation within a single material architecture. Current challenges and future research directions are discussed to support the development of scalable biochar-based technologies for sustainable carbon utilisation.